Discuss This Drug

Etoposide

CHEBI:CHEBI_4911

Chemical Information

Molecular Formula
C29H32O13
Molecular Mass
588.55660
Charge
0
SMILES
[H][C@]12COC(=O)[C@]1([H])[C@H](c1cc(OC)c(O)c(OC)c1)c1cc3OCOc3cc1[C@H]2O[C@@H]1O[C@@H]2CO[C@@H](C)O[C@H]2[C@H](O)[C@H]1O
InChI
InChI=1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1
InChIKey
VJJPUSNTGOMMGY-MRVIYFEKSA-N

Alternative Names

  • (-)-etoposide
  • (5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside
  • 4-demethylepipodophyllotoxin beta-D-ethylideneglucoside
  • 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)
  • 9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-d)-1,3-dioxol-6(5aH)-one
  • Eposin
  • Etopophos
  • etoposide
  • Etoposide
  • Etoposido
  • etoposidum
  • Lastet
  • Toposar
  • trans-Etoposide
  • Vepesid
  • VP-16

Treatment Applications

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000
4179
oboInOwl#hasDbXref
Wikipedia:Etoposide
core#notation
CHEBI:4911

Additional References

Wikipedia:Etoposide

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

chebi#has_functional_parent
http://purl.obolibrary.org/obo/CHEBI_50305
oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
4179
oboInOwl#hasDbXref
Wikipedia:Etoposide
oboInOwl#id
CHEBI:4911
generic_name
ETOPOSIDE
brand_name
ETOPOPHOS
brand_name_base
ETOPOPHOS
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20241231
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
labeler_name
Catalent Germany Eberbach GmBH
marketing_start_date
20010718
product_ndc
63323-104
application_number
ANDA074983
spl_id
d672a555-bb0e-4a82-ac5e-5c9393b59c28
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_59517
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
core#notation
CHEBI:4911
rxcui
1734340
route
INTRAVENOUS
active_ingredient_strength
4 kg/4kg
package_marketing_start_date
20010718
manufacturer_name
Mylan Pharmaceuticals Inc.
pharm_class_epc
Topoisomerase Inhibitor [EPC]
pharm_class
Topoisomerase Inhibitors [MoA]
pharm_class_moa
Topoisomerase Inhibitors [MoA]
active_ingredient_name
ETOPOSIDE PHOSPHATE
package_ndc
63323-104-50
package_description
1 VIAL, MULTI-DOSE in 1 CARTON (63323-104-50) / 50 mL in 1 VIAL, MULTI-DOSE
unii
528XYJ8L1N
spl_set_id
fe870629-104d-4d67-a7c6-f53bc588121e
nui
N0000000176
upc
0363323104504
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
has_treatment
http://purl.obolibrary.org/obo/DOID_4786
rdf-schema#range
https://w3id.org/def/predibionto#has_drug_113878
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect26396
owl#annotatedSource
t231853
owl#someValuesFrom
t711669